Gamida Cell Ltd. - stock earnings

GMDA Quarterly earnings

DateEarningsRevenue
2023Q3 -1.5 million USD 673000 USD
2023Q2 -31.7 million USD ? USD
2023Q1 -22.3 million USD ? USD
2022Q4 -43.4 million USD ? USD
2022Q3 -18.5 million USD ? USD
2022Q2 -36.6 million USD ? USD
2022Q1 -21.1 million USD ? USD
2021Q4 -30.8 million USD ? USD
2021Q3 -19.6 million USD ? USD
2021Q2 -21.3 million USD ? USD
2021Q1 -18.0 million USD ? USD
2020Q4 -32.3 million USD ? USD
2020Q3 -14.8 million USD ? USD
2020Q2 -15.1 million USD ? USD
2020Q1 -10.6 million USD ? USD
2019Q4 -14.7 million USD ? USD
2019Q3 -10.1 million USD ? USD
2019Q2 6.0 million USD ? USD
2019Q1 -15.5 million USD ? USD
2018Q4 -22.6 million USD ? USD
2018Q3 -9.8 million USD ? USD
2018Q2 -13.1 million USD ? USD
2018Q1 -7.4 million USD ? USD
2017Q4 -5.8 million USD ? USD
2017Q3 -3.9 million USD ? USD
2017Q2 -3.8 million USD ? USD
2016Q4 -22.7 million USD ? USD

GMDA Yearly earnings

DateEarningsRevenue
2023 -77.0 million USD 673000 USD
2022 -154.4 million USD ? USD
2021 -92.4 million USD ? USD
2020 -76.4 million USD ? USD
2019 -34.4 million USD ? USD
2018 -52.9 million USD ? USD
2017 -19.0 million USD ? USD
2016 -22.7 million USD ? USD

GMDA

Price: $0.03

52 week price:
0.03
2.51

Earnings Per Share: -0.82 USD

P/E Ratio: -0.47

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 182493

Market Capitalization: 5.3 million

Links: